Piper Sandler lowered the firm’s price target on Amerant Bancorp (AMTB) to $25 from $32 and keeps an Overweight rating on the shares. While the company executed $5M in share repurchases and redeemed $60M in senior notes on April 1 to strengthen the capital structure, these positives will likely be overwhelmed by the renewed uncertainty around credit quality and loan portfolio management, the firm says. Piper is lowering its forward estimates by over 20%, down to $1.75/$2.25 from $2.05/$2.80 previously, on higher expected credit costs, a slightly lower net interest margin, and slower loan growth. The firm still thinks the shares will move notably higher from here over the next 12 months.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMTB:
- Amerant Bancorp price target lowered to $20 from $24 at Keefe Bruyette
- Amerant Bancorp’s Earnings Call: Balancing Growth and Challenges
- Amerant Bancorp Reports Q1 2025 Financial Results
- Amerant Bancorp downgraded to Market Perform from Outperform at Raymond James
- Amerant Bancorp Reports Q1 2025 Earnings Decline